Clinical trial
Efficacy and Safety of a Purified Standardised Bee Venom Preparation
NCT00263952 · Allergopharma GmbH & Co. KG, Industry · Completed
Key facts
| NCT number | NCT00263952 |
|---|---|
| Title | Efficacy and Safety of a Purified Standardised Bee Venom Preparation |
| Official title | Immunotherapy of Bee Venom Allergy: Evaluation of a New Purified Bee Venom Preparation in Comparison With Already Published Studies. |
| Lead sponsor | Allergopharma GmbH & Co. KG, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bee Venom Allergy |
| Intervention type | Biological |
| Interventions | bee venom |
| Start date | Mar 1, 2003 |
| Primary completion | Jan 1, 2005 |
| Completion | Apr 1, 2010 |
| First posted | Dec 12, 2005 |
| Last update posted | Mar 4, 2013 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: